CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO

H-003 / H-003-1ML updated item number format

Hydrocodone

1.0 mg/mL in Methanol |

Certified Reference Material

Hydrocodone is a semi-synthetic opioid derived from codeine or thebaine, two naturally-occurring opiates. The drug, also known as dihydrocodeinone, is used as an analgesic to treat pain and as an antitussive for coughing or related conditions. This Certified Spiking Solution® is suitable as a starting material for calibrators or controls in GC/MS or LC/MS testing applications from pharmaceutical research and pain prescription monitoring to clinical toxicology and forensic analysis.
   
Concentration: 1.0 mg/mL
Solvent: Methanol
Unit Size: 1 mL/ampoule
CAS Number:

125-29-1

Chemical Formula:

C18H21NO3

Molecular Weight:

299.36

Certificate of Analysis:
US List Price:
$27.70 EA
Qty:


H-005 / H-005-1ML    Hydrocodone-D3, 100 μg/mL  
   $38.40      
H-008 / H-008-1ML    Hydrocodone-D3, 1.0 mg/mL  
   $153.00      
H-047 / H-047-1ML    Hydrocodone-D6, 100 μg/mL  
   $43.30      
H-048 / H-048-1ML    Hydrocodone-D6, 1.0 mg/mL  
   $164.00      
N-053 / N-053-1ML    Norhydrocodone HCl, 1.0 mg/mL (as free base)  
   $115.00      
N-054 / N-054-1ML    Norhydrocodone-D3 HCl, 100 μg/mL (as free base)  
   $146.00      
O-020 / O-020-1ML    Opiate Multi-Component Mixture-5, 250 μg/mL of each component  
   $164.00      
P-071 / P-071-1ML    Pain Management Multi-Component Opiate Mixture-13, 100 μg/mL of each component; 10 μg/mL of Fentanyl  
   $441.00      

Regulatory Control
▶  USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶  Canada Test Kit Registration # 61-1213 - no Health Canada import authorization required
read more about ordering regulated substances

Recommended Storage Condition
Freeze

UN Number, Class, PG
1230, 3, II

Safety Data Sheet

HS Code
3822.90.0000

▶  A High-throughput Pain Management Panel in Urine Using IONICS 3Q 120 LC-MS/MS and an SLE Sample Prep Platform | IONICS Mass Spectrometry Group inc., 2014
▶  Advanced Toxicology Testing for Compounds using Core-Shell Technology | Erica A. Guice, Jessica Marsh, Seyed Sajadi, and Matthew Pentis, Western Slope Laboratory, 2012
▶  An Automated Solid Phase Extraction Method for Opiates in Urine | Jeffery Hackett and Michael Telepchak, UCT, Inc., 2012
▶  Comparison of Forensic Tandem Mass Spectral Data Obtained on Portable Instrumentation to an Established Reference Library | Adam E. O’Leary, Seth E. Hall, Herbert M. Oberacher, andChristopher C. Mulligan, llinois State University Department of Chemistry, 2014
▶  Direct Analysis of Opioids and Metabolites from Whole Blood Using Ostro Sample Preparation Plates Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
▶  Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µElution SPE Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
▶  High Throughput Screening and confirmation of 41 Pain Panel Drugs in Oral Fluid by an Integrated On-Line Extraction UHPLC-MS/MS System | Louis Maljers, Zicheng Yang, Bruker Daltonics Inc, 2016
▶  LC-MS (TOF) Analysis of Opioids and Opiate-Dependence Management Drugs on Ascentis® Express HILIC | Sigma-Aldrich®, 2014
▶  LC/MS (TOF) Analysis of Drugs and Their Glucuronide Metabolites on Titan™ C18 after Solid Phase Extraction (SPE) using Supel™-Select SCX, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
▶  LC/MS (TOF) Analysis of Opioid Drugs and Glucuronide Metabolites in Urine on Ascentis® Express 2.7 µm HILIC after SPE using Supel™-Select HLB, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
▶  LC/MS Analysis of Opioid Glucuronide Metabolites in Urine on Ascentis® Express 2.7 µm F5 after Solid Phase Extraction (SPE) using Supel™-Select HLB | Sigma-Aldrich®, 2014
▶  LC/MS/MS Analysis of Drugs of Abuse: Generic Screening on Ascentis® Express F5 | Sigma-Aldrich®, 2015
▶  Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
▶  Proof of Concept/Comparison of Automated SPE/HPLC/MS/MS Methods to Traditional Immunoassay with MS Confirmation in Death Investigation Cases | Robert M. Sears, Wendy C. Bell , Kenneth C. Lewis, Thurman L. Allsup and Kim Gamble, ITSP Solutions, INC., 2014
▶  Rapid Differentiation of Isobaric Drugs Using a Novel Direct Sample Analysis Source, CID, and Accurate Mass TOF Mass Spectrometry | Robert J. Seward, Bonnie Marmor, and Andrew Tyler, PerkinElmer, Inc., 2014


© 2024 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact